Study reveals dramatic rise in ivermectin and hydroxychloroquine prescriptions during COVID-19

U.S. outpatient prescriptions for hydroxychloroquine and ivermectin increased 2- to 10-fold above pre-pandemic rates, respectively, to treat COVID-19, despite strong evidence disproving their effectiveness, new UCLA-led research shows.

Single-cell screening of cerebral organoids to identify developmental defects in autism

Researchers develop CRISPR-human organoids-single-cell RNA sequencing system to identify developmental brain defects in autism.

September 18, 2023

Lilly’s board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 23, 2024

Dexcom plans to launch new CGM this summer for people who don’t take insulin

Dive Brief: Dexcom plans to launch a new continuous glucose monitor this summer for people with Type 2 diabetes who don’t take insulin. The device,

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.